## Abstract [^11^C] Raclopride uptake to dopamine D~2~ receptors was investigated with positron emission tomography (PET) in patients with early Parkinson's disease at the time of the diagnosis and after a half‐year interval. During this progressive period of the disease, the patients received no a
PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease
✍ Scribed by Dr. J. O. Rinne; A. Laihinen; K. Någren; J. Bergman; O. Solin; M. Haaparanta; U. Ruotsalainen; U. K. Rinne
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 609 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Striatal dopamine D-1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early Parkinson's disease using ["CI-SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of ["F]-6-F-DOPA in the striatum contralateral to the symptoms. None of the patients had received any antiparkinsonian medication. The striatal and cerebellar radioactivity was measured and corresponding striaturdcerebellum ratios were counted. The mean striaturdcerebellum ratio of ["CI-SCH 23390 binding was symmetric between the hemispheres. By contrast, the striaturn/ cerebellum ratio of [llC]raclopride binding, labelling dopamine D-2 receptors, was increased significantly in the hemisphere contralateral to the symptoms as compared with the opposite hemisphere. Thus, the present results show that the behaviour of striatal D-1 and D-2 receptors is different in early Parkinson's disease.
📜 SIMILAR VOLUMES
## Abstract The loss of dopaminergic neurons in the substantia nigra provokes a plasticity of corticostriatal synapses in Parkinson's disease (PD). The corticostriatal pathway nevertheless makes synapses with neurons bearing D1 dopamine receptors (D1R) and/or D2 dopamine receptors. At the ultrastru
## Abstract Striatal dopamine D~2~ receptor binding was studied in vivo with positron emission tomography in seven patients with early Parkinson's disease using [^11^C]–raclopride. The patients had unilateral symptoms and none of them had received levodopa treatment. The accumulation of [^11^C]–rac